| Literature DB >> 26319445 |
Anthony F Alario1, Travis D Strong2, Stefano Pizzirani3.
Abstract
Glaucoma is a painful and often blinding group of ocular diseases for which there is no cure. Although the definition of glaucoma is rapidly evolving, elevated intraocular pressure (IOP) remains the most consistent risk factor of glaucoma in the canine patient. Therapy should be aimed at neuroprotection. The mainstay of therapy focuses on reducing IOP and maintaining a visual and comfortable eye. This article discusses the most current ocular hypotensive agents, focusing on their basic pharmacology, efficacy at lowering IOP, and recommended use in the treatment of idiopathic canine glaucoma.Entities:
Keywords: Carbonic anhydrase inhibitors; Delivery systems; Glaucoma; Medical therapy; Novel therapies; Prostaglandin analogues
Mesh:
Substances:
Year: 2015 PMID: 26319445 DOI: 10.1016/j.cvsm.2015.06.004
Source DB: PubMed Journal: Vet Clin North Am Small Anim Pract ISSN: 0195-5616 Impact factor: 2.093